Vacation Scholarships 2010

A list of the Vacation Scholarships awarded for tenure during the summer of 2010 is available to view or download.

Read More

Research Project Awards

The following is a list of those to whose research is currently being supported by Medical Research Scotland.

• Dr V. Anne Smith (School of Biology, St Andrews University) and Drs Simon Langdon & Dr Dana Faratian (Institute of Molecular Medicine & Genetics, Edinburgh University), for a project involving taking a systems biology approach to the development of predictive patient selection for ovarian cancer therapy.
• Dr Andrew J. Childs (MRC Human Reproductive Sciences Unit), Professor R.A. Anderson (Reproductive & Developmental Sciences) and Professor P.T. Saunders (Reproductive Sciences Unit, Edinburgh University), for an investigation of the regulation of germ cell development in the human fetal ovary in an effort to establish reproductive potential.
• Dr Carl S. Goodyear (Clinical Neurosciences, Glasgow University), Professor Margaret Harnett (Immunology, Infection & Inflammation, Glasgow University) & Dr Richard Soutar (Haematology, Gartnavel General Hospital, Glasgow), for a study of the inhibition of osteoclastogenesis by immunomodulatory complexes.[The Vipiana Award]
• Dr Colin Berry Scottish Senior Clinical Research Fellow (BHF Glasgow Cardiovascular Research Centre, Glasgow University), for his work on combining computer modelling and MRI to improve heart attack treatment.
• Dr Christine M. Dufes (Strathclyde Institute of Pharmacy & Biomedical Sciences) and Professor Kevin Ryan (Beatson Institute for Cancer Research, Glasgow), for the evaluation of systemic p73 gene therapy of cancer, using a novel transferring-targeted dendrimer.
• Dr Nancy Sabatier (Centre for Integrative Physiology, University of Edinburgh) for an investigation of hypothalamic mechanisms in obesity.
• Dr John A. Marwick (moving to Edinburgh from the National Hearth & Lung Institute, London) and Professor Adriano G. Rossi (MRC Centre for Inflammation Research, University of Edinburgh), to study the impact of oxidative stress and glucocorticoids on neutrophil function and macrophage clearance.
• Dr Nial J. Wheate, Dr Oliver Sutcliffe & Professor David Flint (Strathclyde Institute of Pharmacy & Biomedical Sciences, Strathclyde University), for a three-year investigation of the mechanisms of folic acid-directed delivery of platinum(II)-based anticancer drugs using PAMAM dendrimers.
• Dr Daniel Walker (Division of Infection & Immunity, Glasgow University), for a two-year study of the antimicrobial activity of novel protein antibiotics against Pseudomonas aeruginosa in the biofilm state.
• Dr Pasquale Maffia & Dr James Brewer (Strathclyde Institute of Pharmacy & Biomedical Sciences, Strathclyde University), for a two-year project on the visualisation of antigen presentation in models of atherosclerosis.
• Dr Andrew J. Roe (Infection & Immunity) & Dr Richard Burchmore (Functional Genomics Facility), University of Glasgow, for an 19-month project aiming to find new ways of blocking the infectivity of Escherichia coli 0157
• Dr David A. Ferenbach and Drs Jeremy Hughes & David Kluth (Centre for Inflammation Research, University of Edinburgh, for a 12-month study of the role of selected cells in protecting against acute kidney failure following acute injury
• Dr Joanna L. Parish (Bute Medical School, University of St Andrews), for a three-year X-ray crystallographic study of an enzyme required for normal cell division and also in persistent papillomavirus infection
• Dr Hironori Ishizaki & Dr Elizabeth Patton (Edinburgh Cancer Centre, University of Edinburgh) for a three-year project aimed at improving understanding of the development of malignant melanoma
• Dr Gareth B. Miles (School of Biology, University of St Andrews) for a three-year project to test the 'synaptic stripping' hypothesis for amyotrophic lateral sclerosis (ALS), by an investigation of cholinergic synapses on motoneurones in ALS.
• Dr Ada Delaney (Centre for Neuroscience Research, Royal [Dick] School of Veterinary Studies) and colleagues, Professor Susan M. Fleetwood-Walker (Centre for Neuroscience Research, Royal [Dick] School of Veterinary Studies), Dr Rory Mitchell (Centre for Integrative Physiology) Dr Lesley Colvin (Department of Anaesthesia, Critical Care & Pain Medicine, Western General Hospital) and Professor Marie Fallon (CRUK Edinburgh Cancer Research Centre, Western General Hospital), all of the University of Edinburgh, for a two-year investigation aimed at gaining new insights into evidence-based pain management for cancer-induced bone pain.
• Dr Andrew C. Stanfield and colleagues Professors Eve Johnstone & Stephen M. Lawrie (all of the Department of Psychiatry, University of Edinburgh) and Professor Peter M. McKenna (Department of Psychological Medicine, University of Glasgow), over 30 months for aclinical, neuropsychological and MRI study comparing autism spectrum disorders and schizophrenia spectrum disorders.
• Dr James W. Dear, Clinical Pharmacology Unit, University of Edinburgh and colleagues Professor David Webb (Centre for Cardiovascular Science), Professor D. Nicholas Batemen (Scottish Poisons Information Bureau, Edinburgh Royal Infirmary), Dr Ian Marshall (Medical Physics Department, University of Edinburgh) & Dr Kenneth J. Simpson (Centre for Inflammation Research, University of Edinburgh) for an 18-month project for the characterisation of paracetamol-induced acute renal failure, using dendrimer-contrast magnetic resonance imaging.
• Drs Mary Donaldson & Iain Morgan (Department of Pathological Sciences, University of Glasgow Veterinary School), over three years to investigate the potential of TopBP1 to be a therapeutic target for human papillomavirus infection.
• Dr Shauna E. Culshaw, Centre for Biophotonics, University of Strathclyde and colleagues Professor Paul Garside, Dr John Girkin, Professor Gail McConnell & Dr James Brewer (all of the Centre for Biophotonics, University of Strathclyde), for a two-year project aimed at improving understanding of the basic mechanisms of the adaptive immune response to cariogenic bacteria in the oral cavity.